1. Predictive AI Model Identifies nAMD Treatment Response Biomarkers

    Predictive AI Model Identifies nAMD Treatment Response Biomarkers

    An artificial intelligence (AI) method designed to predict visual outcomes via a treat-and-extend (T&E) regimen of anti-VEGF therapy ranibizumab in patients with neovascular age-related macular degeneration (nAMD) showed particular benefit of defined—and easily accessible—biomarkers. The new data, presented at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Meeting this week, may contribute the developing field of AI and machine learning for optimizing chronic retinal disease management. Led by Hrvoje Bogunovic, PhD, director of the Christian Doppler Lab for Artificial Intelligence in Retina and associates director of the Laboratory for Ophthalmic Image Analysis at the Medical ...

    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics Mentioned

  3. Authors